Equity Research, Broker Reports, and media content on Beximco Pharmaceuticals

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Beximco Pharmaceuticals
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Beximco Pharmaceuticals. We currently have 36 research reports from 3 professional analysts.

Open
N/A
Range Today
N/A
52 Week
35.0/55.0p
Daily Volume
N/A
# Shares
90.9m
Daily Liquidity
(0.01%)
Pension Liability
Enterprise Value
£4,705m
Market Cap
£32.3m
Latest PE (hist)
0.00
Div Yield
1.92
Date Source Announcement
08Aug19 09:18 RNS Update on Dividend and Tax legislation changes
30Jul19 07:00 RNS Beximco launches fifth product in the US market
18Jul19 16:01 RNS Dividend and Tax changes for Bangladesh companies
29Apr19 07:00 RNS 3rd Quarter Results
24Apr19 07:00 RNS Beximco receives FDA approval for Cyproheptadine
20Feb19 07:00 RNS Beximco Pharma to Acquire Eight ANDAs from Sandoz
04Feb19 11:32 RNS Appointment of Broker
  • Frequency of research reports

     

  • Research reports on

    Beximco Pharmaceuticals

  • Providers covering

    Beximco Pharmaceuticals